09:52 AM EST - Cardiol Therapeutics Inc. : Announced today that Cardiol's Chief Medical Officer, Dr. Andrew Hamer, will be participating in a panel discussion entitled "New World Order for Endo/CV/Renal Disease" at Cantor Fitzgerald's Virtual Rare Orphan Disease Summit on Tuesday, March 29, at 1:00 p.m. EDT. Cardiol Therapeutics Inc.
shares T.CRDL are trading up $0.04 at $1.92.
